BTG2 and lung carcinoma: On the contrary, low expression of genes (BTG2, CD48, CD69, CXCR6, CYBB, IL7R, IL12B, MEP1A, NMUR1, PDE4B, SLAMF1, SLC1A2, SLC11A2, and STAB1) had shorter survival times in lung cancer (Supplementary Figure S2).